about
Applications of nanotechnology in dermatologyNanoparticle ligand presentation for targeting solid tumors18F-Labeled Peptides: The Future Is BrightQuantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingSynthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseasesDesign and applications of bispecific heterodimers: molecular imaging and beyondPeptides and peptide hormones for molecular imaging and disease diagnosisInfluence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Thermodynamic stability and relaxation studies of small, triaza-macrocyclic Mn(II) chelates.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTIn vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.High-yielding aqueous 18F-labeling of peptides via Al18F chelationNear-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7.α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrugSmall molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imagingMicrofluidics for synthesis of peptide-based PET tracers.Alternative Non-Antibody Protein Scaffolds for Molecular Imaging of CancerProspective of ⁶⁸Ga-radiopharmaceutical development.Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.Peptide-based imaging agents for cancer detection.Radiolabeled bombesin derivatives for preclinical oncological imaging.Radiometallated peptides for molecular imaging and targeted therapy.Engineered nanoparticles for biomolecular imaging.Rationale for the use of radiolabelled peptides in diagnosis and therapy.A molecular imaging primer: modalities, imaging agents, and applications.Imaging agents for the chemokine receptor 4 (CXCR4).Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time.Radiolabeled peptide-receptor ligands in tumor imaging.The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.Evaluation of Magnetonanoparticles Conjugated with New Angiogenesis Peptides in Intracranial Glioma Tumors by MRI.Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates.Evaluation of (99m)Tc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice.The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.Apoptosis imaging studies in various animal models using radio-iodinated peptide.In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.Radiolabeled antagonistic bombesin peptidomimetics for tumor targeting.Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of α(v)β(3) integrin receptor.Synthesis of a (68)ga-labeled peptoid-Peptide hybrid for imaging of neurotensin receptor expression in vivo.Metal-Based PSMA Radioligands.
P2860
Q24170384-78CC5736-C628-43B5-B058-FFB557D8F09EQ27009522-13F9E936-A4B0-4D1C-A8F2-88EBB4F8BB50Q27023393-7CD4E985-C058-45B1-A961-B1E9D5649F69Q27023605-4D41681E-C9CE-49DA-A453-2E7383EA542BQ27025187-ADF12C2A-F3AE-485B-A75F-E6191F3AD94BQ33732587-B6377DC9-3419-4560-8133-29580EA20F66Q33846924-77F910DA-AC4C-46A4-B5D4-DD4FA5938FFFQ34250142-A3A0A0E3-1BBC-4DC6-B35D-728026BD17C3Q34460892-A4D78C30-5A8D-42BD-91E5-C07636F51910Q34561711-D9B09878-4D3B-43A1-9941-0A812F71B533Q34912643-6B8AA05A-74B7-47C3-A3EA-ACBAEBDE2C5EQ35180876-23923360-33F2-4584-836B-8553A58FACFDQ35228332-FCDB61D4-5DCC-4B68-AA6F-BDAB44CF9A74Q35541948-3D38BE92-242A-40C6-A9E9-767369C4A35DQ35981228-A5AFABFE-55E6-4CAF-AC9E-BE7670E2B2E1Q36610302-4C333672-7FE0-4C0A-8CB3-05C025DC0171Q37322485-F9EC170F-3D84-40DF-933D-3268BF30FC19Q37394193-84AFA495-189F-44B9-A1A3-507539C25172Q37435222-EF6BB461-0F4C-43B2-B842-B97DB0BFB3A6Q37449406-F0DF2B9E-B569-46AC-A7C7-8440A3F00F58Q37585965-4B691C92-D2BE-448B-A29B-F5CC7EAFA843Q37674035-78B743C2-1CD5-4949-9E06-798C43574CE7Q37847064-85D0DD1B-E37E-4EC7-9DB9-4BA23DA1F6AEQ37895953-802E8DF9-CEB8-4D8D-91C2-4D342FE9CAA2Q37990410-2157A248-A983-420F-B09B-AF4C818D1381Q38005672-EDA4894B-545A-4111-9D76-FDF07DAF4FAAQ38022430-B8794318-152E-43A0-AD42-D63510DBEB9AQ38028657-53FFF584-A6EB-4E15-B7F9-58D821B31D06Q38088748-1C68654D-FC7D-40AD-AF13-A6DB57452DC1Q38217493-E308118D-C6B4-44FC-841C-94CC4AFE043FQ38712836-03C382BB-041F-4571-A42B-E98E4C098AE8Q38722877-BB3D7A02-6D3D-4C76-A0BC-875A9492ADF0Q38829691-7AD062A7-E1FE-496B-928A-925479877C7EQ38876206-F72F45CA-B64C-4E04-AFA8-1AC06A316428Q38937295-494E80CC-EDD9-4248-8FE5-528E8B39E4CEQ38977436-D79D6911-78EA-4675-909C-F62689C206D3Q39044587-12056C4B-D35B-4EAC-824F-1B988A58A8F9Q39144300-0445A670-6DC3-4879-A4BA-B2B9D2B7F60EQ39158998-FD58B82A-335E-48A4-BEC3-0E20F5AE16EFQ39198527-E6168CF1-2CD5-4366-8EF3-1E8CE19CED55
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular imaging targeting peptide receptors.
@en
Molecular imaging targeting peptide receptors.
@nl
type
label
Molecular imaging targeting peptide receptors.
@en
Molecular imaging targeting peptide receptors.
@nl
prefLabel
Molecular imaging targeting peptide receptors.
@en
Molecular imaging targeting peptide receptors.
@nl
P1433
P1476
Molecular imaging targeting peptide receptors.
@en
P2093
Hans-Jürgen Wester
Margret Schottelius
P304
P356
10.1016/J.YMETH.2009.03.012
P577
2009-03-24T00:00:00Z